Hindustan Zinc Limited (HINDZINC), the world’s largest integrated zinc producer, announces record results for the second quarter and half year ended September 30, 2026. The company reported a net profit of ₹6,412 crore, up 142% year-on-year (YoY), driven by a robust increase in mined and refined metal production, higher metal prices, and a stronger dollar.

Record Production and Profitability

The company achieved a record second quarter mined metal production of 271 thousand tonnes (KT), up 5% YoY. Refined metal production also reached a best-ever 264 KT, up 7% YoY. Zinc cost of production excluding royalty was $703 per tonne, better by 29% YoY, due to improved mined grades and increased metal production.

Financial Highlights

Revenue from operations stood at ₹15,093 crore during the quarter, up 77% YoY. The company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) stood at ₹9,285 crore, up 108% YoY. The industry-leading EBITDA margin was maintained at 62%.

Forward-Looking Statement

Commenting on the company’s performance, Amarendu Prakash, Chief Executive Officer, said: “I am honored to lead Hindustan Zinc at this pivotal stage. Our record quarterly mined metal production of 271 KT and refined metal production of 264 KT demonstrates the strength of our operations, assets, and people. We remain focused on disciplined growth, AI-led innovation, and advancing our critical minerals portfolio to support India’s energy transition while delivering long-term stakeholder value.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Hindustan Zinc Limited

Hindustan Zinc Limited belongs to the Basic Materials › Other Industrial Metals & Mining sector. Here’s a quick read on where the business and the stock stand today.

Hindustan posts a 4.2% three-month gain, but softens in the last few weeks. Industry-leading margins of 38.1% reflect exceptional pricing power and operational efficiency. The PEG of 1.40 sits close to fair value. The stock is neither a clear buy nor obviously expensive. The stock gives back 4.8% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at 5.6% and profits at 9.6%, and the dividend yield stands at 2.07%. The business is in good shape. Moreover, a stock that does not move despite strong fundamentals often offers better value than one already priced for perfection. Check Fundamentals of Hindustan Zinc Limited.

Rossari Biotech Limited (ROSSARI) has announced its unaudited financial results for the quarter and half-year ended September 30, 2026, marking a significant milestone with the highest-ever quarterly revenue and EBITDA. The company reported a record quarterly revenue of Rs. 697.6 crores, a 19.0% growth on a year-on-year basis, and an EBITDA of Rs. 87.0 crores, a 20.9% growth on a year-on-year basis.

Record Financial Performance

The company’s consolidated Q2 FY27 performance highlights include: highest-ever quarterly revenue of Rs. 697.6 crores, highest-ever quarterly EBITDA of Rs. 87.0 crores, and an EBITDA margin of 12.5%, up by 20 bps. Despite higher depreciation due to investments in long-term projects, the Profit After Tax stood at Rs. 38.9 crores. Additionally, export sales reached Rs. 216.4 crores, a 33.8% growth on a year-on-year basis.

Strategic Growth Initiatives

Rossari Biotech Limited has also made significant progress in its strategic initiatives. The Board has approved the leasing of land for setting up a greenfield manufacturing facility in the Kingdom of Saudi Arabia (KSA). This marks a key milestone in Rossari’s international growth journey. The company continues to focus on strengthening its balance sheet and improving cash flow generation, with net working capital cycle improved to 86 days as of September 2026 from 97 days as of March 2026.

With strong R&D capabilities, expanding capacities, a healthy balance sheet, and a growing global footprint, Rossari Biotech Limited is well-positioned to deliver sustained long-term growth.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Rossari Biotech Limited

Rossari Biotech Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Rossari falls 14.4% over three months and has not found a floor yet. Thin margins at 5.9% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Not a single revenue dip or loss quarter in five years — this is a business built to last through cycles. The stock gains 3.9% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 13.1% and profits at 11.6% CAGR, with D/E of 0.18. Meanwhile, the stock dips 14.4% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Rossari Biotech Limited.

Vedanta Limited (NSE: VEDL) has announced the doubling of its annual zinc production capacity to 500,000 tonnes at its South Africa zinc operations through an investment of nearly $600 million at Gamsberg (Phase II) at Vedanta Zinc International (VZI). This expansion marks one of the largest mining investments in South Africa this decade and further advances Vedanta Limited’s position as the world’s largest zinc producer, with a vision of achieving 3 million tonnes of annual production across India and South Africa.

Strategic Expansion

Gamsberg, in South Africa’s Northern Cape province, has one of the world’s most significant zinc deposits and VZI’s flagship zinc mine. The expansion is part of the $1.5 billion investment commitment Vedanta made at the 2018 South Africa Investment Conference. South African President Cyril Ramaphosa and Vedanta Limited Director Priya Agarwal-Hebbar inaugurated this expansion, underscoring the growing economic partnership between India and South Africa.

Global Zinc Leadership

Zinc consumption is growing rapidly as it is essential to modern industrial and infrastructure development. Through galvanization, it protects steel, the world’s most widely used metal, from corrosion, extending its service life and supporting applications across construction, automotive, manufacturing, and other sectors. This expansion forms part of Vedanta Limited’s ambition to build a globally significant zinc and industrial hub in the region, creating lasting value for the country and its people.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Vedanta Limited

Vedanta Limited belongs to the Basic Materials › Other Industrial Metals & Mining sector. Here’s a quick read on where the business and the stock stand today.

Vedanta trades in the lower quarter of its 52-week range. The PEG of 0.58 signals undervaluation relative to growth. It is a potential re-rating candidate. D/E of 1.40 is elevated. As a result, debt servicing will compress free cash flow in a high-rate environment. The stock sits at 0% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at -19.2% and profits at 18.0% CAGR — a genuinely strong business. Nevertheless, the stock drops 2.8% in three months. The market sells the stock, not the story. Watch whether that changes at the next earnings. Check Fundamentals of Vedanta Limited.